Blood Test for Diagnosing Active and Latent Tuberculosis
Checks how well a blood test detects tuberculosis in adults.
Plain-language title generated from the registry record
Registry title: Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
Key facts
- Where
- Marseille, FranceSee the site
Where in France
- Assistance Publique Hôpitaux de MarseilleMarseille, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique Hopitaux De Marseille
- Trial code
- NCT06485895
- Record updated
- 1 August 2024
- Original description
Methodology This is a single-center study carried out as part of routine patient care.Read full original descriptionShow less
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
Methodology This is a single-center study carried out as part of routine patient care.
The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.
Inclusion: Individual at least 18 years of age; Patient presenting for treatment of tuberculosis disease; Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test; Informed patient who has not expressed opposition to participating in the study; French-speaking patient with unambiguous understanding of oral and written instructions.
Exclusion: Persons in a period of exclusion from another study; Pregnant, parturient or breast-feeding women; Person deprived of liberty by judicial or administrative decision.